Evidence map›Paper›PMID 31106972›Full record

ArticleArthritis & rheumatology (Hoboken, N.J.)2019

A Link Between Plasma Microbial Translocation, Microbiome, and Autoantibody Development in First-Degree Relatives of Systemic Lupus Erythematosus Patients.

Elizabeth Ogunrinde, Zejun Zhou, Zhenwu Luo, Alexander Alekseyenko, Quan-Zhen Li, Danielle Macedo, Diane L Kamen, Jim C Oates, Gary S Gilkeson, Wei Jiang

Open access · greenAbstract read
In one paragraph

Article in Arthritis & rheumatology (Hoboken, N.J.), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed, 3 pooled it
7.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 3 syntheses or guidelines pooled it, 80 citations in OpenAlex.

  1. Pooled it
  2. Mucosal immune response in biology, disease prevention and treatment.Signal transduction and targeted therapy · 2025
    Pooled it
  3. Pooled it
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Observational
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 3 countries.

Elizabeth OgunrindeMedical University of South Carolina, Charleston.
Zejun ZhouHunan Normal University College of Life Sciences, Changsha, China.
Zhenwu LuoMedical University of South Carolina, Charleston.
Alexander AlekseyenkoMedical University of South Carolina, Charleston.
Quan-Zhen LiUniversity of Texas Southwestern Medical Center, Dallas, Texas.
Danielle MacedoUniversidade Federal do Ceará, Fortaleza, Brazil.
Diane L KamenMedical University of South Carolina, Charleston.
Jim C OatesMedical University of South Carolina and Ralph H. Johnson VA Medical Center, Charleston, South Carolina.
Gary S GilkesonMedical University of South Carolina and Ralph H. Johnson VA Medical Center, Charleston, South Carolina.
Wei JiangMedical University of South Carolina, Charleston.ORCID 0000-0002-1374-053X
Medical University of South Carolina · USHunan Normal University · CNThe University of Texas Southwestern Medical Center · USUniversidade Federal do Ceará · BR

Funding

Translational Science Laboratory Shared ResourceP30CA138313 · NCI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI Jian Ouyang · 2009 to 2026
$42.7M
South Carolina Clinical & Translational Research Institute (SCTR)UL1TR001450 · NCATS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI BRADY, KATHLEEN T., FLUME, PATRICK A · 2015 to 2024
$41.1M
ZINC AND COPPER METABOLISM IN COLLAGEN DISORDERSM01RR001070 · NCRR · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI REVES, JOSEPH G · 1985 to 2009
$16.3M
SOUTH CAROLINA CLINICAL & TRANSLATIONAL RESEARCH INSTITUTE (SCTR)UL1RR029882 · NCRR · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI BRADY, KATHLEEN T. · 2009 to 2011
$10.1M
Resource CoreP30AR072582 · NIAMS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI JAMES C OATES · 2017 to 2026
$8.5M
Translational Center of Molecular Profiling in Preclinical and Established Lupus (COMPEL)P50AR070591 · NIAMS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI BUYON, JILL P · 2017 to 2021
$6.7M
South Carolina Cancer Disparities Research Center (SC CADRE)U54CA210962 · NCI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI FORD, MARVELLA ELIZABETH, SALLEY, JUDITH · 2017 to 2023
$6.7M
South Carolina Cancer Disparities Research Center (SC CaDRe)U54CA210963 · NCI · SOUTH CAROLINA STATE UNIVERSITY · PI FORD, MARVELLA ELIZABETH, SALLEY, JUDITH · 2017 to 2023
$6.1M
Patient Resource CoreP60AR062755 · NIAMS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI GILKESON, GARY S · 2012 to 2016
$5.8M
Training Grant in Inflammatory and Fibrosing DiseasesT32AR050958 · NIAMS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI DIANE L KAMEN · 2005 to 2026
$4.2M
Prospective Study of Human Oral Microbiome and Pancreatic Cancer RiskR01CA164964 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI AHN, JIYOUNG · 2014 to 2017
$2.2M
Distance-based Panomic Analytics for Microbiome DataR01LM012517 · NLM · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI ALEKSEYENKO, ALEXANDER V · 2018 to 2021
$1.3M
Biorepository & Tissue Analysis Shared ResourceBrazilian Institution CNPqCSRD VA I01 CX001211Medical Research Service at the Ralph H. Johnson VA Medical Center CX-001211NCATS NIH HHS R21 TR002513NCATS NIH HHS UL1 TR001450NCI NIH HHS P30 CA138313NCI NIH HHS R01 CA164964NCI NIH HHS U54 CA210962NCI NIH HHS U54 CA210963NCRR NIH HHS M01 RR001070NCRR NIH HHS UL1 RR029882NIAID NIH HHS R01 AI128864NIAMS NIH HHS K24 AR068406NIAMS NIH HHS P30 AR072582NIAMS NIH HHS P50 AR070591NIAMS NIH HHS P60 AR062755NIAMS NIH HHS R21 AR067459NIAMS NIH HHS T32 AR050958NLM NIH HHS R01 LM012517
6 · The paper itself

Abstract

objectiveSystemic lupus erythematosus (SLE) is characterized by the production of antibodies against self antigens. However, the events underlying autoantibody formation in SLE remain unclear. This study was undertaken to investigate the role of plasma autoantibody levels, microbial translocation, and the microbiome in SLE.

methodsPlasma samples from 2 cohorts, one with 18 unrelated healthy controls and 18 first-degree relatives and the other with 19 healthy controls and 21 SLE patients, were assessed for autoantibody levels by autoantigen microarray analysis, measurement of lipopolysaccharide (LPS) levels by Limulus amebocyte assay, and determination of microbiome composition by microbial 16S ribosomal DNA sequencing.

resultsFirst-degree relatives and SLE patients exhibited increased plasma autoantibody levels compared to their control groups. Parents and children of lupus patients exhibited elevated plasma LPS levels compared to controls (P = 0.02). Plasma LPS levels positively correlated with plasma anti-double-stranded DNA IgG levels in first-degree relatives (r = 0.51, P = 0.03), but not in SLE patients. Circulating microbiome analysis revealed that first-degree relatives had significantly reduced microbiome diversity compared to their controls (observed species, P = 0.004; Chao1 index, P = 0.005), but this reduction was not observed in SLE patients. The majority of bacteria that were differentially abundant between unrelated healthy controls and first-degree relatives were in the Firmicutes phylum, while differences in bacteria from several phyla were identified between healthy controls and SLE patients. Bacteria in the Paenibacillus genus were the only overlapping differentially abundant bacteria in both cohorts, and were reduced in first-degree relatives (adjusted P [P

conclusionsThese results indicate a possible role of plasma microbial translocation and microbiome composition in influencing autoantibody development in SLE.

Indexed as

Bacterial TranslocationFamilyAdolescentAdultAntibodies, AntinuclearAutoantibodiesCase-Control StudiesChildDNAFemaleHumansLipopolysaccharidesLupus Erythematosus, SystemicMaleMicrobiotaMiddle AgedAntibodies, AntinuclearAutoantibodiesDNALipopolysaccharides

Identifiers

PMID31106972
PMCPMC6817371
OpenAlexW2945260285

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.